$370,000 of METLIFE GROUP INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 2547, Secure Family Futures Act of 2025, all provisions; S. 1335, Secure Family Futures Act of 2025, all provisions. Issues relating to escheatment. Issues related to providing E-delivery of documents for ERISA health and welfare benefit products; the Voluntary Excepted and Supplemental Benefits Protection Act (bill not yet introduced); H.R. 1521, Doc Access Act of 2025, all provisions; S.1716, Vision Lab Choice Act of 2025, all provisions. Issues related to retirement market expansion including mandated auto-IRAs, 401k, 403(b) parity, and enrollment. Issues pertaining to the FSOC dedesignation process; to improve the transparency of the Financial Stability Oversight Council, to improve the SIFI designation process, and for other purposes; Issues relating to the use of artificial intelligence (AI) in financial services and insurance; Issues related to federal data security, cybersecurity, and consumer data privacy standards for insurance and financial institutions. H.R. 6644,21st Century ROAD to Housing Act, issues related to Section 901."
You can find more data on corporate lobbying on Quiver Quantitative.
MET Insider Trading Activity
MET insiders have traded $MET stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MET stock by insiders over the last 6 months:
- MARLENE DEBEL (EVP & Chief Risk Officer) sold 21,312 shares for an estimated $1,738,822
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MET Hedge Fund Activity
We have seen 542 institutional investors add shares of MET stock to their portfolio, and 634 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,553,796 shares (+12.6%) to their portfolio in Q1 2026, for an estimated $177,335,594
- ABN AMRO BANK N.V. removed 2,101,814 shares (-96.1%) from their portfolio in Q1 2026, for an estimated $145,949,964
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,771,689 shares (+133.5%) to their portfolio in Q1 2026, for an estimated $123,026,084
- GOLDMAN SACHS GROUP INC added 1,706,652 shares (+37.9%) to their portfolio in Q1 2026, for an estimated $118,509,914
- BLACKROCK, INC. added 1,389,701 shares (+2.8%) to their portfolio in Q1 2026, for an estimated $96,500,837
- DIAMOND HILL CAPITAL MANAGEMENT INC removed 1,282,992 shares (-35.3%) from their portfolio in Q1 2026, for an estimated $89,090,964
- BANK OF NEW YORK MELLON CORP removed 1,241,561 shares (-25.8%) from their portfolio in Q1 2026, for an estimated $86,213,995
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MET Price Targets
Multiple analysts have issued price targets for $MET recently. We have seen 13 analysts offer price targets for $MET in the last 6 months, with a median target of $98.0.
Here are some recent targets:
- Yaron Kinar from Mizuho set a target price of $102.0 on 07/09/2026
- Wesley Carmichael from Wells Fargo set a target price of $101.0 on 07/09/2026
- Michael Ward from UBS set a target price of $105.0 on 07/08/2026
- Alex Scott from Barclays set a target price of $94.0 on 07/07/2026
- Nigel Dally from Morgan Stanley set a target price of $103.0 on 07/06/2026
- Paul Newsome from Piper Sandler set a target price of $90.0 on 06/24/2026
- Ryan Krueger from Keefe, Bruyette & Woods set a target price of $98.0 on 05/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
